| Number |
Title
|
| 88-23 |
Phase I/II Study of Integrated Intra-Arterial CDDP and Intravenous I131-Antiferritin in the Treatment of Nonresectable Hepatocellular Cancer
|
| 84-05 |
Phase I/II Dose-Escalating Trial of Accelerated Fractionation in the Palliative Irradiation of Hepatic Metastases from Primary Cancer of the GI Tract
|
| 83-19 |
Phase III Randomized Comparison of ADR/5-FU plus I131-Antiferritin IgG vs ADR/5-FU Alone Following ADR/5-FU plus External Beam Radiotherapy in Nonmetastatic Nonresectable Primary Hepatoma
|
| 83-01 |
Phase I/II Escalating ADR/5-FU Integrated with Isotopic Immunoglobulin Following Radiotherapy plus ADR/5-FU for Liver Cancer
|
| 80-03 |
Phase III Comparison of Radiation Alone vs Radiation plus Misonidazole in the Treatment of Liver Metastases
|
| 79-28 |
Phase I-II Study of Combined Modality Treatment of Primary Liver Cancer with Isotopic Immunoglobulin, Liver Irradiation, and ADR/5-FU
|
| 76-05 |
Pilot Study of Radiotherapy for Palliation of Symptomatic Hepatic Metastases
|
